Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
0.7252
+0.0052 (0.73%)
Feb 19, 2026, 12:49 PM EST - Market open
Immuron Market Cap
Immuron has a market cap or net worth of $6.67 million as of February 19, 2026. Its market cap has decreased by -42.48% in one year.
Market Cap
6.67M
Enterprise Value
2.61M
1-Year Change
-42.48%
Ranking
Category
Stock Price
$0.73
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $6.67M, a decrease of -76.26%. That is a compound annual growth rate of -15.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 17, 2026 | 4.10M | -8.89% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Addex Therapeutics | 7.34M |
| Aptevo Therapeutics | 7.13M |
| Moolec Science | 6.96M |
| Liminatus Pharma | 6.93M |
| Revelation Biosciences | 6.65M |
| PharmaCyte Biotech | 6.60M |
| Theriva Biologics | 6.44M |
| Aptorum Group | 6.42M |